Synthetic biology spawns fresh approach to antibiotics

The amazingly hot field of synthetic biology has now spawned an engineered virus that attacks bacteria. Timothy Lu, a doctoral student in the Harvard-MIT Division of Health Sciences and Technology, says he and colleagues created the virus by drawing from a library of genes. In this particular case, the researchers took a gene that produced the enzyme dispersin B and inserted it into the genome of the T7 virus. The enzyme is known to degrade bacteria's molecular "scaffolding." At a later stage, he says, the scientists should be able to design new viruses engineered to attack specific bacteria. And these new viruses could be used to create a new generation of antibiotics--as well as industrial cleaners.

- read the report from MSNBC

ALSO: The New York Times' Nicholes Wade reviews the potential of synthetic biology after J. Craig Venter announced plans to develop new forms of synthetic life. At MIT, one program's to-do list includes "grow a house." Article

Suggested Articles

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.